2. Audit
• Ward 23
Admissions + Transfer in – 355
Mortality - 02
• Ward 29
Admissions + Transfer in – 322
Mortality - 02
• Clavien – Dindo Classification – Grade II
3. Mrs P G Lasanthi, 34yrs old female from Kahathuduwa
Thyroid goiter for 4 months
USS – L/S Thyroid nodule +Level III LN
FNAC - ? Medullary/Hurthle cell CA
S.Ca2+
S.Calcitonin NAD
24hr Urinary Metanephrines
USS Abd
4. Total Thyroidectomy + L/S Selective Neck
Dissection done
• Level VI
LN clearance done
• L/S Level II, III, IV, Vb
• 2 drains placed – Thyroid bed & Posterior Triangle
• Histology – Papillary CA + 5/25 LN positive
5. • Post op Day 1 – No voice change
No hypocalcemic features
Drain = 95ml
• Post op Day 3 – Drain = 315ml
? Chyle leak
• Post op Day 5 – Drain = 650 ml – High output chyle leak (>500ml)
6. Conservative Management
• Prop up – 45o
• S/C Octreotide 100 mcg tds
• Nutritional referral – Medium chain fatty acid diet
• IV Cefuroxime 750mg tds
• Lactulose
• Tight dressing
• Suction drain
• Hydration
• No hyponatremia, hypochloremia & clotting derangement
8. • Post op Day 8 – Drain = 300 ml
• Post op Day 12 – Drain = 120 ml
• Post op Day 21 – Drain = Nil
• Post op Day 23 - Discharged
9. Root Cause Analysis
T.T + L/S
Functional Neck
Dissection
Chyle Leak
(High out put)
Conservative
Management
Chyle leak
persists
Chyle leak
persists
Surgical
exploration
1)Transabdominal
embolization
2)Thoracoscopic
ligation
1)Low Fat Diet
2)Remove drain
3)Octreotide
additional 2 days
Yes No
10. Literature Review
• Intraoperative identification
Valsalva maneuver
Manual abdominal compression
• Conservative management
Diet – MCFA + Orlistat
TPN – High out put
Compression dressing – controversial
Octreotide
• Topical agents – Sclerosing agents
Fibrin glue
11. Literature Review cont
• Surgical interventions – High out put > 5days/ no prompt response to medical Mx
Re-exploration Ligation of Thoracic duct
Cover with muscle flap
Distal embolization – success rate 45-70 %
Thoracoscopic ligation of Thoracic duct
12. Literature Review cont.
• Retrospective study
• Octreotide therapy appears superior to
traditional conservative measures
• Reduce hospital stay
• 1st line conservative management